Literature DB >> 27468604

[NEW OPPORTUNITIES IN NEURO-REHABILITATION: ROBOT MEDIATED THERAPY IN CONDITONS POST CENTRAL NERVOUS SYSTEM IMPAIRMENTS].

Gábor Fazekas, Ibolya Tavaszi, András Tóth.   

Abstract

Decreasing the often-seen multiple disabilities as a consequence of central nervous system impairments requires broadening of the tools of rehabilitation. A promising opportunity for this purpose is the application of physiotherapy robots. The development of such devices goes back a quarter of century. Nowadays several robots are commercially available both for supporting upper and lower limb therapy. The aim is never to replace the therapists, but rather to support and supplement their work. It is worthwhile applying these devices for goal-oriented exercises in high repetition, which one physically fatiguing for the therapist or for the correction of functional movement by various strategies. Robot mediated therapy is also useful for motivation of the patient and making the rehabilitation programme more versatile. Robots can be used for assessment of the neuromotor status as well. Several clinical studies have been executed in this field, all over the world. Meta-analyses based on randomized, controlled trials show that supplementing the traditional physiotherapy with a robot-mediated component presents advantage for the patients. Further studies are necessary to clarify which modality and intensity of the exercises, in which group of patients, in which stage lead to the expected outcome.

Entities:  

Mesh:

Year:  2016        PMID: 27468604     DOI: 10.18071/isz.69.0148

Source DB:  PubMed          Journal:  Ideggyogy Sz        ISSN: 0019-1442            Impact factor:   0.427


  1 in total

1.  Changes in kinesiostabilogram parameters and movement speed of stroke patients while increasing their physical activity due to the use of biofeedback method.

Authors:  Victoria Zaborova; Anatoly Fesyun; Konstantin Gurevich; Alevtina Oranskaya; Alexey Rylsky; Kira Kryuchkova; Vladimir Malakhovskiy; Dmitry Shestakov
Journal:  Eur J Transl Myol       Date:  2021-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.